找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG

[復制鏈接]
樓主: energy
11#
發(fā)表于 2025-3-23 10:15:59 | 只看該作者
Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: EpidemiologiCKD than in general population, and its frequency increases progressively with the severity of CKD varying in different CKD causes including renal artery stenosis (93%), diabetic nephropathy (87%), and polycystic kidney disease (74%). The pathogenesis of hypertension associated with chronic kidney d
12#
發(fā)表于 2025-3-23 15:11:51 | 只看該作者
13#
發(fā)表于 2025-3-23 19:38:31 | 只看該作者
14#
發(fā)表于 2025-3-24 01:56:13 | 只看該作者
15#
發(fā)表于 2025-3-24 02:35:33 | 只看該作者
Risk Stratification of Resistant Hypertension in Chronic Kidney Disease, pressure on optimal doses of three or more antihypertensive agents, ideally one being a diuretic. It causes cardiovascular and renal complications. RHTN may be a part of chronic kidney disease (CKD). RHTN diagnosis should be made early and treatment should be effective. Because it is a significant
16#
發(fā)表于 2025-3-24 07:35:08 | 只看該作者
17#
發(fā)表于 2025-3-24 14:09:48 | 只看該作者
Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease,t organ for hypertension-induced damage. The association between hypertension and chronic kidney disease (CKD) is well known. The prevalence of hypertension increases and control of hypertension becomes more difficult as kidney functions decline. Understanding of the pathophysiology of hypertension
18#
發(fā)表于 2025-3-24 17:11:32 | 只看該作者
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Arterial Stiffening,ong time. Increased arterial stiffness is a major nontraditional cardiovascular risk factor in CKD reflecting the difficulty of the large arteries to convert flow oscillations into continuous blood flow due to significant morphological changes induced by this pathological condition. Surrogate marker
19#
發(fā)表于 2025-3-24 21:00:25 | 只看該作者
20#
發(fā)表于 2025-3-25 01:20:18 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
京山县| 衡阳县| 琼结县| 建湖县| 忻州市| 武冈市| 长泰县| 昭苏县| 彰化县| 和静县| 齐河县| 合水县| 黎川县| 上思县| 巴楚县| 长顺县| 元江| 南部县| 青海省| 昭觉县| 若尔盖县| 莫力| 禹州市| 平果县| 青阳县| 邮箱| 吉隆县| 瑞安市| 荆州市| 壶关县| 建昌县| 长乐市| 武陟县| 泾川县| 西乌| 中卫市| 南投县| 高雄市| 若羌县| 昌都县| 宽甸|